A dysregulated acetyl/SUMO switch of FXR promotes hepatic inflammation in obesity. (25th November 2014) - Kim, Dong‐Hyun
Abstract Elevated acetylation of the mouse nuclear Farnesoid X receptor (FXR) in obesity inhibits its SUMOylation, which promotes hepatic inflammation and metabolic dysfunction in vivo.